BioCentury
ARTICLE | Company News

BioChain Institute Inc., Epigenomics sales and marketing update

March 18, 2013 7:00 AM UTC

Epigenomics granted BioChain Chinese rights to Epigenomics' septin 9 (SEPT9) biomarker to detect colorectal cancer (CRC) in blood. BioChain said it would immediately begin efforts to "validate and de...